Antibodies, Lymphokines, andReagents. The monoclonal anti-IL-4 antibody, 11BIl (18) , was prepared by ammonium sulfate precipitation of hybridoma culture SNs . Affinity-purified anti-IL-2 mAb, S4B6 (4) and anti-murine IFN-y, XMG1 .2 (7) have been described. The anti-IL-2-R antibody (7134) (19) was prepared by ammonium sulfate precipitation of culture SNs from the 7134 hybridoma (American Type Culture Collection, Rockville, MD) . Rabbit anti-human IL-1(i, which is crossreactive with mouse IL-1(i, was generously provided by Dr. R . Newton (DuPont Glenolden Laboratory, Glenolden, PA) . A polyclonal antibody (rabbit) to IL-la was purchased from Cistron Technology (Pine Brook, NJ) . A monoclonal directed against natural human IL-1, which is crossreactive with murine IL-1, was purchased from Genzyme (Boston, MA) . IL-4 was purified from SNs of Con A-stimulated T286 cells according to the method described by Ohara, et al . (20) . IL-4 preparations lacked IL-2 and IFN-y activities and their stimulatory effect on the proliferation of HT-2, T286, and HDK-1 cells could be completely inhibited by the monoclonal anti-IL-4 antibody, 111311 . 1 U of IL-4 was defined as the reciprocal of the dilution of SN containing 50% of the maximal stimulatory activity of a standard IL-4 preparation in the HT-2 proliferation assay. Murine rIL-4 1 Abbreviations used in this paper: KLH, keyhole-limpet hemocyanin ; p, maximal proliferation ; SAC, splenic adherent cells ; SN, supernatant. and rIFN-y were prepared at DNAX (Palo Alto, CA) ; human rIL-2 was purchased from AMGen (Thousand Oaks, CA), and human rIL-1a and a were obtained from Cistron Technology.
Lymphokine Assays. IL-2 and IL-4 activities were assayed by their ability to induce the proliferation of HT-2 cells, as described (21) and by specific inhibition by anti-IL-2 or anti-IL-4 antibodies, respectively. Briefly, HT-2 cells were plated in 96-well plates (5 x 103 cells/well) together with different dilutions of Th cell SNs in the presence and absence of anti-IL-2 (S4B6) or anti-IL-4 (111311) antibodies. After 24 h of incubation at 37'C/7 .50/0 C02, ['H]thymidine (1 gCi/well) was added, the plates were cultured for an additional 16 h, harvested, and counted . IFN-y was assayed by its ability to inhibit the proliferation of WEHI-279 cells (17) . In this assay, WEHI-279 cells were plated in 96-well plates at a density of 105 cells/ml with different dilutions of Th cell SNs or a standard rIFN-y preparation in the presence or absence of the anti-IFN-y antibody, XMG1.2 (7) .
[3H]Thymidine (1 RCi/well) was added after 24 h of incubation, and the cells were harvested and counted 16 h later.
Proliferation of Th Cells. Stimulation ofT286 (Th2) or HDK-1 (Thl) cells was accomplished by culturing the Th cells (24- well plates) at a density of 5 x 105/ml in the presence of KLH (50-100 ug/ml) and syngeneic splenic adherent cells (SAC) for 24 h at 37°C. The SAC were prepared by removing the nonadherent cell fraction from culture wells previously seeded with 7 .5 x 106 irradiated spleen cells and incubated for 2 h at 37°C . After 24 h of stimulation, the T cells were washed three times with balanced salt solution, 1% FCS, separated from SAC and dead cells by centrifugation through Ficoll (Pharmacia Fine Chemicals, Uppsala, Sweden), and subsequently cultured at a density of 106/ml in RPMI-1640-10% FCS medium with no added lymphokines . Cells were harvested at different times during the secondary culture, and their proliferative response to IL-2 or IL-4 in the presence or absence of other lymphokines (IFN-y, IL-1) was measured using a 36-h proliferation assay. Briefly, T286 (Th2) or HDK-1 (Thl) cells were harvested, washed two times in BSS-1% FCS, and incubated in 96-well plates at a density of 2 x 105 cells/ml in the presence of the indicated concentrations of lymphokines .
[3H]Thymidine (1 gCi/well) was added after 24 h of culture, and the cells were incubated for an additional 16 h at 37'C. The cells were then harvested and counted .
[3H]Thymidine incorporation was taken as a measure of proliferation .
Staining. Cells were stained for IL-2-R after the indicated times of culture . Briefly, the cells were incubated for 30 min at 4°C with biotinylated (B) anti-IL-2R (7134) antibodies in PBS-azide (10 mM)-1% FCS, followed by three washes . Cells were incubated with FITCavidin (Vector Laboratories, Burlingame, CA), counterstained with propidium iodide (5 wg/ml) (in order to exclude dead cells), and were analyzed on the FAGS.
Results
Thl and Th2 Clones. Two clones of similar antigenic specificity (KLH) and MHC restriction (IAd), but belonging to different Th subtypes, were chosen for comparison. HDK-1 and T-286 clones have been classified as Thl and Th2 subtypes, respectively, based on their pattern of lymphokine secretion after antigenic or mitogenic stimulation (4, 7) . Thl cells secrete IL-2 and IFN-y, whereas Th2 cells secrete IL-4 (7, 11) . Table I shows the lymphokine levels secreted after antigenic stimulation, as detected by biological assays and inhibition with monoclonal anti-lymphokine antibodies. Results have also been confirmed by hybridization ofcytoplasmic RNA with lymphokine-specific cDNA probes (7, 11) . Both clones are able to provide antigenspecific, MHC-restricted help to B cells under conditions ofcognate interaction (8) .
Responsiveness of Thl and Th2 Cells to IL-2 and IL-4 after Antigenic Stimulation. In previous experiments, we have observed that after antigenic stimulation, Th2 cells secrete IL-4 and proliferate in response to both IL-4 and IL-2 (11, 14) . Although Thl cells would be expected to acquire responsiveness to IL-2 in a similar manner, it was not clear whether Thl cells would respond to IL-4 after antigenic stimulation . Culture SN from antigen-stimulated HDK-1 and T-286 cells were collected after a 24-h incubation of the T cells (T) at a density of 5 x 10 5 cells/ml with KLH (50 lag/ml) and irradiated (3,300 rad) SAC from BALB/c mice . After filtration (0 .22 w), the T cell SNs were tested for the presence of IL-2, IL-4, and IFN-y, as described in Materials and Methods . Results are from a representative experiment.
We thus compared the responsiveness of Thl and Th2 cells with both IL-2 and IL-4 at various times after antigenic stimulation. In addition, we examined the maintenance of responsiveness as a function of the time in culture after removal of both the antigen and the secreted lymphokines.
As shown in Fig. 1 , antigenic stimulation resulted in the acquisition of responsiveness by the two types of Th clones to both IL-2 ( (19) , demonstrated that the levels of expression of IL-2R, as measured by the mean fluorescence intensity, followed a similar course to that described for IL-2 responsiveness . IL-2-R levels increased as a result of antigenic stimulation and then gradually returned to baseline levels (results not shown) .
The IL-4-mediated Proliferation of Th1 Cells Is not Mediated by Endogenously-produced IL-2. Although it is clear that HT 2 and Th2 cells respond to IL-4 and IL-2 independently (11, 21) , the possibility existed that the proliferation of Thl cells observed in the presence of IL-4 was the result of endogenous production and utilization of IL-2 as a consequence of IL-4 stimulation. To determine whether this was the case, Thl cells were harvested 1-2 d after initial activation and assayed for their ability to proliferate in response to IL-4 in the presence of anti-IL-2 or anti-IL-4 antibodies . As shown in Table II , the presence of anti-IL-2 antibodies at concentrations that completely inhibited IL-2-mediated proliferation had no effect on the IL-4-mediated proliferation of the Thl cells, while the anti-IL-4 antibodies completely inhibited such responses. These results suggest that the IL-4-mediated proliferation of Thl cells cannot be attributed to the endogenous production of IL-2, unless IL-2 can deliver a signal to the receptor inside the cell before exposure to the antibody.
Effects ofIFN-y on Thl and Th2 Proliferation. Although IFN-y is known to inhibit the effects of IL-4 on B cells (17, (22) (23) (24) (25) (26) , no effects on the IL-4-mediated proliferation of Th cells have been reported . In this regard, the ability of Thl and Th2 cells to proliferate in response to IL-2 or IL-4 was measured in the presence of increasing concentrations of rIFN-y (1-50 U/ml). As shown in Fig. 2 in the responses of Th cells to antigens (27) (28) (29) and, more recently, to IL-4 has been reported by several groups (13, 30, 31) . This prompted us to investigate the effects of IL-1 on the proliferation of Thl and Th2 cells after antigenic stimulation and to determine whether IL-1 was required for IL-4-mediated proliferation. rIL-la or rIL-1Q alone did not show any proliferative activity at doses up to 10 U/ml . However, both forms of IL-1 synergized with IL-2 or IL-4 in the proliferation of Th2 cells. In contrast, rIL-1 (a or R) had very little effect on the proliferation of Thl cells. Fig. 3 (A-D) shows the effects of IL-1 on the proliferative response of Thl and Th2 cells to IL-2 and IL-4 . Interestingly, the enhancement of proliferation was most evident when the cells were harvested 2 d after antigenic stimulation . The addition of anti-IL-1 antibodies at doses that completely inhibited IL-1 activity (a and a) (10 U/ml) in a thymocyte proliferation assay (32), had no effect on the proliferation of HDK-1 or T-286 cells to IL-4 . In fact, even when such antibodies inhibited the synergy between IL-1 and IL-4 on T-286 cells, they were unable to inhibit proliferation beyond that attained with IL-4 alone (Table III) . These results suggest that although IL-1 is able to synergize with IL-4, IL-1 is not an absolute requirement for the proliferation of some Th2 clones .
Synergy between IL-2 andIL-4. Since both Thl and Th2 cells are able to proliferate in response to IL-2 and IL-4 shortly after antigenic stimulation, we next investigated the effects of a mixture of IL-2 and IL-4 on the proliferation of both Thl and Th2 cells. As shown in Fig. 4 (A and B) (33) (34) (35) or IgGi secretion (35, 36) , respectively. We thus determined whether IL-4 could act before IL-2 (or vice versa) at inducing a synergistic proliferative response in Th cells. In these experiments, we studied the synergistic response of Th2 (T-286) cells because of their higher response to IL-4 . Th2 cells were harvested 4-5 d after activation (when cells are no longer proliferating) and were cultured in microtiter wells with medium alone or with either IL-2 or IL-4 at concentrations giving similar proliferative responses (time 0) . At different times, IL-2 and IL-4 were added to wells containing medium alone, IL-4 was added to wells containing IL-2, and IL-2 was added to wells containing IL-4 . The cells were then cultured for 36 h and proliferation was measured . As shown in Figure 6 , synergistic responses (when compared with cells cultured with IL-2 or IL-4 only) were observed irrespectively of which lymphokine was added first. Cells cultured with either IL-2 or IL-4 during the first phase of the culture gave a better proliferative response than those receiving medium alone, suggesting that the presence of either lymphokine was required to maintain Kinetics of the Synergy between IL-2 and IL-4: Wash-out Experiment. To investigate whether the signal provided by the first lymphokine could be separated from the signal provided by the second, T286 cells were cultured as described for the delayed addition experiment, except that the first lymphokine was washed out before the second lymphokine was added. In control cultures, cells were incubated in the absence of lymphokines during the first phase of culture and with both or either lymphokine during the second phase of culture. As shown in Fig. 7 , and in contrast to the previous experiment, synergy was observed only when both lymphokines were provided simultaneously. If the first lymphokine was removed before the addition of the second, synergy was not observed and proliferation was comparable with that attained in the presence of the second lymphokine alone. These results suggest that in order for IL-2 and IL-4 to synergize, both must be present at the same time .
Discussion
In the present report, we have compared the IL-2-and IL-4-mediated responses of two KLH-specific, I-Ad-restricted Th clones, one of the Thl type, and the other of the Th2 type . We have also studied the effects of IFN-y and IL-1 on the IL-2- Secretion of lymphokines by both Th subsets is not constitutive, but is dependent on mitogenic or antigenic stimulation (4, 7, 11) . Moreover, when harvested at the end of their normal rest period (7-14 d), cells are unresponsive to the growth-promoting effects of IL-2 or IL-4, indicating that activation through the TCR induces lymphokine secretion and responsiveness . This responsiveness is probably mediated by the up-regulation of membrane receptors for IL-2 and IL-4 . In vivo, such proliferation should be self limited, allowing for the controlled expansion of the activated Th cells. Indeed, after activation in vitro, lymphokine release is complete by 24-48 h (37), and our results have shown a progressive decrease in responsiveness to both IL-2 and IL-4 associated with a down-regulation in the density of IL-2-R .
The relationship between the two types of Th cell subsets in vivo is not yet understood. It is unclear whether the two subsets represent different lineages or different stages of the same lineage. In either case, in vivo immunization would probably lead to the activation of antigen-specific Th cells from both subsets, even though the precursor frequencies might differ depending on the antigen used . The fact that Th2 cells up-regulate IL-2-R and proliferate in response to IL-2 to a greater degree than to IL-4, suggests that in order for an optimal response to occur, Thl cells would also have to be activated. Based on our results, we would predict that shortly after antigenic stimulation, IL-2 and IL-4 produced by Thl and Th2 cells, respectively, would not only be used by both autocrine and paracrine mechanisms, but that their combined effects would be synergistic, especially when the responsiveness of both subsets decreases and less than optimal levels of lymphokines are available. On the other hand, IFN-y production by Thl cells would regulate Th2 cell function by downregulating proliferation and would also inhibit the effects of IL-4 on B cells (17, (22) (23) (24) (25) (26) .
Our results are in agreement with those of Kurt Jones et a1 . (31) who demonstrated that Th2 cells respond more effectively to IL-4 than do Thl cells. In contrast to our results, however, their Thl clones did not respond to IL-4 at all. This discrepancy can be explained by the fact that they assayed the responsiveness of their clones to IL-4 after 8 d of culture. Thus, our Thl cells, although responsive to IL-4 soon after antigenic stimulation, lose their responsiveness to IL-4 rapidly, becoming unresponsive after 4 d, while still retaining responsiveness to IL-2 .
The decrease in the responsiveness of Thl and Th2 cells to IL-2 correlates with a concomitant decrease in the levels of IL-2-Rs. However, the antibody used to detect IL-2-R reacts with both high-and low-affinity IL-2-R (p55 subunit) (38) and, as such, a precise estimation of the number of biologically relevant high-affinity IL-2-R (39) that are responsible for the proliferative response, cannot be made IL-1 has been reported to be a cofactor required for the responses of certain Th cells to antigenic stimulation (27) (28) (29) . More recently, several Th2 cells such as D.10G4 (42) and CDC25 (43) have also been reported to require the presence of IL-1 in order to respond to IL-4 (13, 31) . In our initial experiments, however, we observed significant proliferation of our Thl or Th2 cells in the absence of added IL-1 . The possibility exists, however, that contaminating macrophages from the APC cells used during stimulation, provide a source of IL-1 . Arguing against this, the addition of anti-IL-1 antibodies at concentrations that inhibited IL-1 activity (a and R) in a thymocyte proliferation assay were unable to affect the response of Thl or Th2 cells to IL-4, suggesting that not all Th2 cells require IL-1 in order to respond to IL-4 . Nevertheless, although the failure of anti-IL-1 antibodies to inhibit the IL-4-mediated proliferation of Th2 cells would argue against the need for soluble IL-1, we cannot rule out a potential role for membrane-bound IL-1 in IL-4-mediated proliferation of Th cells. An alternative explanation is that shortly after activation, Th2 cells are able to respond to IL-4 alone, but as they lose their responsiveness to this lymphokine, IL-1 can act as cofactor enabling them to respond to IL-4 . In fact, Kupper et al . (13) reported that antigen-stimulated D.10G4 cells are able to respond to IL-4 in the absence of IL-1 shortly after stimulation. Manger et al . (44) have also reported that activated human T cells do not require IL-1 for induction of proliferation (after anti-CD3 stimulation) while resting T cells do require IL-1 . Moreover, the addition of IL-1 to the T-286 cells, even when not absolutely required, had synergistic effects on the IL-2-and IL-4-mediated proliferation, indicating that IL-1 can potentiate the effects of IL-4 (and IL-2). Such synergistic effects have also been observed in D.10G4 cells (13) . In contrast to Th2 cells, IL-1 had little or no effect on the IL-2-or IL-4-mediated proliferation of Thl cells. Such results are in agreement with those of Kurt Jones et al . (31) , who also reported that Th2, but not Thl, cells are responsive to IL-1, and suggested that Th2 cells express higher numbers of high-affinity IL-1-R .
From a functional point of view, the synergy between IL-2 and IL-4 could provide a mechanism for a cooperative response between the two Th cell subtypes . From a biochemical perspective, it suggests that the pathways of IL-2-and IL-4-mediated proliferation are interrelated . Results from wash-out experiments indicate that IL-2 and IL-4 must be present simultaneously in order for synergy to occur. It is possible that synergy requires simultaneous signalling through both IL-2-R and IL-4-R, either independently of each other or through some type of receptor/receptor interaction . Indeed, hormone-induced receptor interactions, as manifested by changes in the affinity or number of receptors for a second hormone, are often accompanied by synergy between the two hormones or by imitation of the effects of one hormone by the other (reviewed in reference 45). Along these lines, Walker et al . (46) have demonstrated a hierarchical pattern of receptor interactions, as evidenced by receptor down-regulation, among receptors for several hemopoietic growth factors, including IL-3, granulocyte-monocyte colony stimulating factor (GM-CSF), granulocyte-CSF (G-CSF) and monocyte-CSF (M-CSF). We have obtained evidence for an IL-4-mediated down-regulation of IL-2-Rs, suggesting a potential IL-4-R/IL-2-R interaction (Fernandez-Botran, R., V. M. Sanders, and E . S. Vitetta, manuscript in preparation) . There are, therefore, several mechanisms that could operate in vivo to amplify initial stimulation of both Th subsets and, subsequently, turn-off their responses. A hypothetical scenario would be that antigenic stimulation in the context of cognate interaction induces lymphokine secretion (IL-2, IL-4, and IL-1) and upregulation in the number of IL-2-R and IL-4-R, resulting in the acquisition of responsiveness to the secreted lymphokines and leading to increased proliferation of both Th subsets (to IL-2 and IL-4 as a result of synergy amongst the three lymphokines). IFN-Y would act by regulating both Th2 proliferation and the effects of IL-4 on B cells. Antigen depletion would then result in cessation of lymphokine secretion and decreased responsiveness due to a reduction in the number of IL-2 and IL-4 receptors . These effects would result in a return of the T cells to a non-dividing state.
In addition to the reported effects of IL-2, IL-4, IFN -'Y, and IL-1 on the proliferation of Th1 and Th2 cells, such lymphokines might also affect another aspect of Th cell function, such as lymphokine secretion. The possibility is currently being investigated . Moreover, regulation at the level of the Th cells will eventually lead to regulation at the level of B cell activation and differentiation . Indeed, both Th clones used in these studies are able to provide help to B cells (4) and induce the secretion of different IgG isotypes . (8) .
Interpretation of the data reported here could be more complicated if there is additional heterogeneity among Th cell subtypes or differences between cloned Th cells and normal Th cells (6) . Recently, different laboratories have reported the existence in human (9) and mouse (10) 
